Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 5

The effect of automated hemolysis index measurement on sample and test rejection rates

Otomatize hemoliz indeks ölçümünün numune ve test red oranlarına etkisi

Pages
630–634
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When compared two periods, statistically significant increase in rejected sample number due to hemolysis in 2014 is result of, visually undetectable hemolyzed samplespreviously can be identified by HIL method (p < 0.05).Conclusion: Usage of hemolysis index program in automated systems for detecting hemolysis was evaluated as a method which is standardized, semi-quantitative, withhigh reproducibility and allows test based rejection

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractObjective: Vast majority of laboratory errors occurs in preanalytical phase and in vitro hemolysis is the most common among preanalytical errors.
📊
Key Findings & Data:Automated serumindex measurement is being used in routine biochemical analysis in Antalya Public Health Care Laboratory, since June 2014.
💡
Conclusion & Impact:When compared two periods, statistically significant increase in rejected sample number due to hemolysis in 2014 is result of, visually undetectable hemolyzed samplespreviously can be identified by HIL method (p < 0.05).Conclusion: Usage of hemolysis index program in automated systems for detecting hemolysis was evaluated as a method which is standardized, semi-quantitative, withhigh reproducibility and allows test based rejection
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

AbstractObjective: Vast majority of laboratory errors occurs in preanalytical phase and in vitro hemolysis is the most common among preanalytical errors. Automated serumindex measurement is being used in routine biochemical analysis in Antalya Public Health Care Laboratory, since June 2014. Our aim in this study is to reveal the impact of serum index usage on rejected samples and rejected test rates due to hemolysis.Materials and methods: Hemolysis, icterus and lipemia (HIL) spectral interference reagent and program have been used in our laboratory since June 2014. In the currentstudy, the number of samples and tests that were rejected due to hemolysis in June–August 2014 were compared with those rejected in the same period of 2013.Results: In 2014, the sample rejection rate was 2.53% and the rejected test rate was 0.48%. In 2013, the sample rejection rate was 0.56% and the rejected test rate was 0.55%. When compared two periods, statistically significant increase in rejected sample number due to hemolysis in 2014 is result of, visually undetectable hemolyzed samplespreviously can be identified by HIL method (p < 0.05).Conclusion: Usage of hemolysis index program in automated systems for detecting hemolysis was evaluated as a method which is standardized, semi-quantitative, withhigh reproducibility and allows test based rejection

Özet

ÖzAmaç: Laboratuvar hatalarının büyük kısmı preanalitik fazda oluşmakta ve in vitro hemoliz en sık rastlanan preanalitik hatalar arasında yer almaktadır. Haziran 2014 tarihinden itibaren, Antalya Halk Sağlığı Laboratuvarında rutin biyokimyasal analizlerde otomatize serum indeks ölçümü kullanılmaya başlanmıştır. Bu çalışmanın amacı serum indeks kullanımının hemoliz nedeniyle reddedilen numuneler ve testlere etkisini belirlemektir.Gereç ve Yöntemler: Laboratuvarımızda Haziran 2014 tarihinden itibaren Hemoliz, İkter, Lipemi (HIL) spektral interferans reaktifi ve programı kullanılmaya başlanmıştır. Mevcut çalışmada 2014 yılı Haziran-Ağustos aylarında hemoliz nedeniyle reddedilen numune ve test sayıları 2013 yılı aynı döneminde reddedilenler ile karşılaştırıldı.Sonuçlar: 2014 yılında numune red oranı %2.53 ve reddedilen test oranı %0.48 olarak saptanmıştır. 2013 yılında ise numune red oranı %0.56 ve reddedilen test oranı %0.55 olarak bulunmuştur. İki dönem karşılaştırıldığında 2014 yılında hemoliz nedeniyle reddedilen numune sayısındaki istatistiksel olarak anlamlı artışın (p < 0.05) nedeni daha önce gözle tespit edilemeyen hemolizli numunelerin HIL yöntemi ile saptanması olarak değerlendirilmiştir.Tartışma: Otomatize biyokimya sistemlerinde hemolizin saptanması amacıyla, hemoliz indeks programının kullanılması, standardize, semi-kantitatif, tekrarlanabilirliği yüksek ve test bazında numune reddini sağlayan bir yöntem olarak değerlendirilmiştir.

🔖

Cite This Article

ERKAL, F. A., AYKAL, G., YALÇINKAYA, H. M., AKSOY, N., ÖZDEMİR, M. (2022). The effect of automated hemolysis index measurement on sample and test rejection rates. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 5, 630–634. https://ajindex.com/articles/620904

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Beastall GH. Adding value to laboratory medicine: a professional responsibility. Clin Chem Lab Med 2013;51:221–7
  2. Carraro P, Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 2007;53:1338–42
  3. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764–72
  4. Aykal G, Yegin A, Aydın O, Yılmaz N, Ellidag HY. The impact of educational interventions on reducing the rejection rates in the preanalytical phase. Turk J Biochem 2014;39:562–6
  5. Lippi G, Gianfranco C, Camilla M. Critical review and metaanalysis of spurious hemolysis in blood samples collected from intravenous catheters. Biochem Med 2013;23:193–200
  6. Lippi G, Mario P, Savatore DS, Gianfranco C. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Cli Lab Sci 2011;48:143–53
  7. Kirchner MJ, Funes VA, Adzet CB, Clar MV, Escuer MI, Girona JM, et al. Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience. Clin Chem Lab Med 2007;45:672–7
  8. Lippi G, Salvagno GL, Blanckaert N, Giavarina D, Green S, Kitchen S, et al. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin Chem Lab Med 2009;47:934–9
  9. Lippi G, Salvagno GL, Montagnana M, Giorgio B, Gian CG. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44:311–6
  10. Howanitz P, Lehman CM, Jones BA, Mejer FA, Horowitz GL. Practices for identifying and rejecting hemolyzed specimens are highly variable in clinical laboratories. Arch Pathol Lab Med 2015;139:1014–9
  11. Luksic AH, Gabaj NN, Miler M, Dukic L, Bakliza A, Simundic AM. Visual assessment of hemolysis affects patient safety. Clin Chem Lab Med 2018;56:574–81
  12. Simundic AM, Nikolac N, Ivankovic V, Ruzic DF, Magdic B, Kvaternik M, et al. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009;47:1361–5
  13. Lippi G, Cadamuro J, Meyer A, Simundic AM. Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med 2018;56:718–27
  14. Gabaj NN, Miler M, Vrtaric A, Hemar M, Filipi P, Kocijancic M, et al. Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Cou